Evonik Industries (FRA:EVK) has been assigned a €37.00 ($43.02) target price by investment analysts at Deutsche Bank in a research note issued on Monday, Borsen Zeitung reports. The firm presently has a “buy” rating on the stock. Deutsche Bank’s price objective would suggest a potential upside of 40.31% from the company’s current price.
Several other research firms also recently commented on EVK. Bank of America set a €24.00 ($27.91) target price on shares of Evonik Industries and gave the stock a “sell” rating in a report on Friday, September 20th. Sanford C. Bernstein set a €30.00 ($34.88) target price on shares of Evonik Industries and gave the stock a “buy” rating in a report on Monday, November 11th. DZ Bank reissued a “buy” rating on shares of Evonik Industries in a report on Wednesday, November 6th. Baader Bank set a €29.50 ($34.30) target price on shares of Evonik Industries and gave the stock a “buy” rating in a report on Thursday, November 21st. Finally, UBS Group set a €20.00 ($23.26) target price on shares of Evonik Industries and gave the stock a “sell” rating in a report on Tuesday, November 5th. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company. Evonik Industries presently has an average rating of “Hold” and an average price target of €28.24 ($32.84).
EVK stock opened at €26.37 ($30.66) on Monday. Evonik Industries has a one year low of €26.78 ($31.14) and a one year high of €32.97 ($38.34). The company’s fifty day moving average price is €24.94 and its 200-day moving average price is €24.29.
Evonik Industries Company Profile
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.